Association between vitamin D and adiponectin and its relationship with body mass index: The META-Health Study

Frontiers in Public Health

Volumn 2, Issue OCT, 2014, Pages

  Bidulescu, Aurelian ^a   Morris, Alanna A ^b   Stoyanova, Neli ^a   Meng, Yuan Xiang ^a   Vaccarino, Viola ^c   Quyyumi, Arshed A ^b   Gibbons, Gary H ^d  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Adiponectin; African Americans; Minorities; Obesity; Vitamin D

Indexed keywords

EID: 85019784002     PISSN: None     EISSN: 22962565     Source Type: Journal    
DOI: 10.3389/fpubh.2014.00193     Document Type: Article

References (38)

1. Oda E. Obesity-related risk factors of cardiovascular disease. Circ J (2009) 73:2204-5. doi:10.1253/circj.CJ-09-0653
2. Ogden CL, CarrollMD,McDowellMA, Flegal KM. Obesity among adults in the United States -no change since 2003-2004. NCHS data brief no 1. Hyattsville, MD: National Center for Health Statistics (2007).
3. Perez Perez A, Ybarra Munoz J, Blay Cortes V, de Pablos Velasco P. Obesity and cardiovascular disease. Public Health Nutr (2007) 10:1156-63. doi:10.1017/ S1368980007000651
4. Pischon T, Nothlings U, Boeing H. Obesity and cancer. Proc Nutr Soc (2008) 67:128-45. doi:10.1017/S0029665108006976
5. Zalesin KC, Franklin BA, Miller WM, Peterson ED, McCullough PA. Impact of obesity on cardiovascular disease. Endocrinol Metab Clin North Am (2008) 37:663-84. doi:10.1016/j.ecl.2008.06.004
6. Holick MF. Vitamin D status: measurement, interpretation, and clinical appli-cation. Ann Epidemiol (2009) 19:73-8. doi:10.1016/j.annepidem.2007.12.001
7. OuchiN,Kihara S,AritaY,OkamotoY,MaedaK,KuriyamaH, et al.Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signal-ing through a cAMP-dependent pathway. Circulation (2000) 102:1296-301. doi:10.1161/01.CIR.102.11.1296
8. Ouchi N, Shibata R,Walsh K. Cardioprotection by adiponectin. Trends Cardio-vasc Med (2006) 16:141-6. doi:10.1016/j.tcm.2006.03.001
9. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med (2008) 168:1174-80. doi:10.1001/archinte.168.11.1174
10. Wang TJ, PencinaMJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, et al.Vitamin D deficiency and risk of cardiovascular disease. Circulation (2008) 117:503-11. doi:10.1161/CIRCULATIONAHA.107.706127
11. Walsh K. Adipokines, myokines and cardiovascular disease. Circ J (2009) 73:13-8. doi:10.1253/circj.CJ-08-0961
12. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care (2007) 30:980-6. doi:10.2337/dc07-0745
13. Vaidya A, Forman JP, Hopkins PN, Seely EW,Williams JS. 25-Hydroxyvitamin D is associated with plasma renin activity and the pressor response to dietary sodium intake in Caucasians. J Renin Angiotensin Aldosterone Syst (2011) 12:311-9. doi:10.1177/1470320310391922
14. Young KA, Engelman CD, Langefeld CD, Hairston KG, Haffner SM, Bryer-Ash M, et al. Association of plasma vitamin D levels with adiposity in His-panic and African Americans. J Clin Endocrinol Metab (2009) 94:3306-13. doi:10.1210/jc.2009-0079
15. Gannage-Yared MH, Chedid R, Khalife S, Azzi E, Zoghbi F, Halaby G. Vita-min D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. Eur J Endocrinol (2009) 160:965-71. doi:10.1530/EJE-08-0952
16. Nimitphong H, Chanprasertyothin S, Jongjaroenprasert W, Ongphiphad-hanakulB.The association between vitaminDstatus and circulating adiponectin independent of adiposity in subjectswith abnormal glucose tolerance. Endocrine (2009) 36:205-10. doi:10.1007/s12020-009-9216-9
17. Vaidya A. Vitamin D and cardio-metabolic disease. Metabolism (2013) 62:1697-9. doi:10.1016/j.metabol.2013.08.009
18. Morris AA, Zhao L, Patel RS, Jones DP, Ahmed Y, Stoyanova N, et al. Differ-ences in systemic oxidative stress based on race and the metabolic syndrome: the Morehouse and Emory team up to eliminate health disparities (META-Health) study. Metab Syndr Relat Disord (2012) 10:252-9. doi:10.1089/met. 2011.0117
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 28:412-9. doi:10.1007/BF00280883
20. Maunsell Z, Wright DJ, Rainbow SJ. Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measure-ment of the 25-hydroxy metabolites of vitamins D2 and D3. Clin Chem (2005) 51:1683-90. doi:10.1373/clinchem.2005.052936
21. Bidulescu A, Liu J, Musani SK, Fox ER, Samdarshi TE, Sarpong DF, et al. Asso-ciation of adiponectin with left ventricular mass in blacks: the Jackson Heart Study.CircHeart Fail (2011) 4:747-53. doi:10.1161/CIRCHEARTFAILURE.110. 959742
22. Egan KM, Signorello LB, Munro HM, Hargreaves MK, Hollis BW, Blot WJ. Vitamin D insufficiency among African-Americans in the southeastern United States: implications for cancer disparities (United States). Cancer Causes Control (2008) 19:527-35. doi:10.1007/s10552-008-9115-z
23. Vaidya A, Forman JP, Underwood PC, Hopkins PN, Williams GH, Pojoga LH, et al. The influence of body mass index and renin-angiotensin-aldosterone system activity on the relationship between 25-hydroxyvitamin D and adiponectin in Caucasian men. Eur J Endocrinol (2011) 164:995-1002. doi:10. 1530/EJE-11-0025
24. Vaidya A, Williams JS, Forman JP. The independent association between 25-hydroxyvitamin D and adiponectin and its relation with BMI in two large cohorts: the NHS and the HPFS. Obesity (Silver Spring) (2012) 20:186-91. doi:10.1038/oby.2011.210
25. Kim M, NaW, Sohn C. Correlation between vitamin D and cardiovascular dis-ease predictors in overweight and obese Koreans. J Clin Biochem Nutr (2013) 52:167-71. doi:10.3164/jcbn.12-81
26. Ulutas O, Taskapan H, Taskapan MC, Temel I. Vitamin D deficiency, insulin resistance, serum adipokine, and leptin levels in peritoneal dialysis patients. Int Urol Nephrol (2013) 45:879-84. doi:10.1007/s11255-012-0308-8
27. de Luis DA, Soto GD, Conde R, Izaola O, de la Fuente B. Relation of leptin and adiponectin with cardiovascular risk factors, intact parathormone, and vitamin D levels in patients with primary hyperparathyroidism. J Clin Lab Anal (2012) 26:398-402. doi:10.1002/jcla.21541
28. Parikh S, Guo DH, Pollock NK, Petty K, Bhagatwala J, Gutin B, et al. Circulat-ing 25-hydroxyvitamin D concentrations are correlated with cardiometabolic risk among American black and white adolescents living in a year-round sunny climate. Diabetes Care (2012) 35:1133-8. doi:10.2337/dc11-1944
29. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest (2002) 110:229-38. doi:10.1172/JCI15219
30. Lee KW, Lip GY. Insulin resistance and vascular remodelling, in relation to left ventricular mass, geometry and function: an answer to LIFE? J Hum Hypertens (2003) 17:299-304. doi:10.1038/sj.jhh.1001561
31. Engeli S,Negrel R, Sharma AM. Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension (2000) 35:1270-7. doi:10.1161/ 01.HYP.35.6.1270
32. Kim S, Soltani-Bejnood M, Quignard-Boulange A, Massiera F, Teboul M, Ail-haudG, et al. The adipose renin-angiotensin systemmodulates systemicmarkers of insulin sensitivity and activates the intrarenal renin-angiotensin system. J Bio-med Biotechnol (2006) 2006:27012. doi:10.1155/JBB/2006/27012
33. Yasue S,Masuzaki H,Okada S, Ishii T, Kozuka C, Tanaka T, et al. Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: impact of nutritional status and adipocyte hypertrophy. AmJHypertens (2010) 23:425-31. doi:10.1038/ajh.2009.263
34. Scragg R, SowersM, Bell C. Serum25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care (2004) 27:2813-8. doi:10.2337/diacare.27.12.2813
35. Chiu KC, Chu A,Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr (2004) 79:820-5.
36. Konradsen S,Ag H, Lindberg F,Hexeberg S, Jorde R. Serum1,25-dihydroxy vita-min D is inversely associated with bodymass index. Eur J Nutr (2008) 47:87-91. doi:10.1007/s00394-008-0700-4
37. Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J, et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab (2004) 89:1196-9. doi:10.1210/jc.2003-031398
38. Wortsman J,Matsuoka LY, Chen TC, Lu Z,HolickMF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr (2000) 72:690-3.